A detailed history of Azzad Asset Management Inc /Adv transactions in Astrazeneca PLC stock. As of the latest transaction made, Azzad Asset Management Inc /Adv holds 61,093 shares of AZN stock, worth $4.07 Million. This represents 0.53% of its overall portfolio holdings.

Number of Shares
61,093
Previous 61,795 1.14%
Holding current value
$4.07 Million
Previous $4.82 Billion 1.24%
% of portfolio
0.53%
Previous 0.57%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 07, 2024

SELL
$76.67 - $87.62 $53,822 - $61,509
-702 Reduced 1.14%
61,093 $4.76 Billion
Q2 2024

Jul 30, 2024

SELL
$66.81 - $80.83 $30,465 - $36,858
-456 Reduced 0.73%
61,795 $4.82 Billion
Q1 2024

Apr 19, 2024

BUY
$61.03 - $69.57 $119,862 - $136,635
1,964 Added 3.26%
62,251 $4.22 Billion
Q4 2023

Apr 01, 2024

BUY
$61.89 - $69.28 $33,791 - $37,826
546 Added 0.91%
60,287 $4.06 Billion
Q3 2023

Apr 01, 2024

BUY
$64.85 - $71.7 $48,832 - $53,990
753 Added 1.28%
59,741 $4.05 Billion
Q2 2023

Apr 01, 2024

SELL
$69.91 - $75.81 $726,225 - $787,514
-10,388 Reduced 14.97%
58,988 $4.22 Billion
Q1 2023

Apr 01, 2024

BUY
$63.15 - $71.6 $46,036 - $52,196
729 Added 1.06%
69,376 $4.82 Billion
Q4 2022

Apr 01, 2024

SELL
$54.21 - $70.44 $1.22 Million - $1.59 Million
-22,511 Reduced 24.69%
68,647 $4.65 Billion
Q3 2022

Apr 01, 2024

BUY
$53.02 - $135.75 $90,770 - $232,404
1,712 Added 1.91%
91,158 $4.97 Billion
Q2 2022

Apr 01, 2024

BUY
$59.26 - $71.14 $1.53 Million - $1.83 Million
25,748 Added 40.42%
89,446 $5.71 Billion
Q1 2022

Apr 01, 2024

BUY
$55.72 - $67.12 $448,378 - $540,114
8,047 Added 14.46%
63,698 $4.23 Billion
Q4 2021

Apr 01, 2024

BUY
$54.02 - $63.83 $1.64 Million - $1.94 Million
30,384 Added 120.25%
55,651 $3.24 Billion
Q3 2021

Apr 01, 2024

BUY
$55.56 - $60.79 $88,007 - $96,291
1,584 Added 6.69%
25,267 $1.52 Billion
Q2 2021

Apr 01, 2024

BUY
$48.42 - $60.18 $20,481 - $25,456
423 Added 1.82%
23,683 $1.42 Billion
Q1 2021

Apr 01, 2024

BUY
$47.16 - $54.44 $341,344 - $394,036
7,238 Added 45.18%
23,260 $1.16 Billion
Q4 2020

Apr 01, 2024

BUY
$48.52 - $58.02 $22,513 - $26,921
464 Added 2.98%
16,022 $801 Million
Q3 2020

Apr 01, 2024

BUY
$53.07 - $61.1 $37,149 - $42,770
700 Added 4.71%
15,558 $853 Million
Q2 2020

Apr 01, 2024

SELL
$43.1 - $55.31 $4,353 - $5,586
-101 Reduced 0.68%
14,858 $786 Million
Q1 2020

Apr 01, 2024

SELL
$37.79 - $51.33 $543,457 - $738,176
-14,381 Reduced 49.01%
14,959 $668 Million
Q4 2019

Apr 01, 2024

BUY
$42.46 - $50.46 $3,354 - $3,986
79 Added 0.27%
29,340 $1.51 Billion
Q3 2019

Apr 01, 2024

BUY
$40.12 - $45.47 $219,657 - $248,948
5,475 Added 23.02%
29,261 $1.43 Billion
Q2 2019

Apr 01, 2024

SELL
$37.28 - $41.68 $969 - $1,083
-26 Reduced 0.11%
23,786 $982 Million
Q1 2019

Apr 01, 2024

BUY
$35.49 - $43.02 $8,446 - $10,238
238 Added 1.01%
23,812 $963 Million
Q4 2018

Apr 01, 2024

SELL
$36.86 - $41.49 $22,890 - $25,765
-621 Reduced 2.57%
23,574 $895 Million
Q3 2018

Apr 01, 2024

BUY
$34.76 - $39.72 $10,497 - $11,995
302 Added 1.26%
24,195 $957 Million
Q2 2018

Apr 01, 2024

BUY
$34.55 - $37.05 $825,503 - $885,235
23,893 New
23,893 $839 Million
Q1 2018

Apr 03, 2024

BUY
$32.97 - $36.63 $77,413 - $86,007
2,348 Added 11.16%
23,380 $818 Million
Q4 2017

Apr 03, 2024

BUY
$32.09 - $34.78 $39,181 - $42,466
1,221 Added 6.16%
21,032 $730 Million
Q3 2017

Apr 03, 2024

SELL
$28.96 - $34.0 $1.17 Million - $1.38 Million
-40,476 Reduced 67.14%
19,811 $671 Million
Q4 2012

Apr 08, 2024

SELL
N/A
-15,040 Closed
0 $0
Q3 2012

Apr 08, 2024

SELL
N/A
-45,247
15,040 $720 Million

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $206B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Azzad Asset Management Inc /Adv Portfolio

Follow Azzad Asset Management Inc /Adv and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Azzad Asset Management Inc /Adv, based on Form 13F filings with the SEC.

News

Stay updated on Azzad Asset Management Inc /Adv with notifications on news.